Subscribe To
Apollomics announces report of activity of vebreltinib in glioblastoma multiforme (gbm) with ptprz-met fusion
FOSTER CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (the “Company”), today announced a report by the Veneto Ins...
October 26, 2023, 12:50 pm
Volitionrx to present cancer detection abstracts at european oncology conference
VolitionRx (NYSE-A:VNRX) said it will be presenting three scientific abstracts about cancer detection tools at the annual congress of the European Soc...
October 16, 2023, 10:11 am
Transcode therapeutics stock skyrockets on positive brain cancer trial results
TransCode Therapeutics (NASDAQ:RNAZ) shares took off after it announced positive results from a study of its lead drug candidate TTX-MC138 in mice mod...
September 25, 2023, 10:38 am
Medicinova announces abstract regarding mn-166 (ibudilast) in glioblastoma accepted for presentation at the annual meeting of the society for neuro-oncology
LA JOLLA, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
August 17, 2023, 11:00 pm
Northwest bio: is there ever going to be a right time?
Northwest Biotherapeutics is a biotech focused on developing a dendritic cell vaccine to fight cancer. The company has faced financial challenges and ...
August 17, 2023, 4:56 pm
Iq ai shares surge following promising subsidiary announcement
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) surged in early-Thursday trades following a promising update from its subsidiary Imaging Biometrics. Imaging Biometr...
July 13, 2023, 5:58 am
Iq-ai subsidiary wins orphan drug status for pediatric brain tumour treatment
Imaging Biometrics, a wholly-owned subsidiary of IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF), been has granted orphan drug designation (ODD) status for its oral...
July 13, 2023, 2:43 am
Why is black diamond therapeutics (bdtx) stock up 82%?
Black Diamond Therapeutics (NASDAQ: BDTX ) stock is seeing massive gains on Tuesday after releasing data from the dose escalation portion of the Phase...
June 27, 2023, 11:00 am
Iq-ai notes positive outcomes from recent pediatric brain tumour studies
IQ-AI Ltd's (LSE:IQAI, OTCQB:IQAIF) wholly-owned subsidiary Imaging Biometrics has noted the outcomes of two pre-clinical studies at the latest Socie...
June 27, 2023, 5:21 am
Brain cancer canada awards cad 80,000 grant to fund innovative glioblastoma research
Brain Cancer Canada, a leading charity dedicated to funding research and technology for breakthrough treatments for brain cancer patients, has awarded...
May 11, 2023, 6:29 pm
In8bio stock price falls even as company receives fda orphan drug status for brain cancer treatment
IN8bio (NASDAQ:INAB), Inc shares slid 16% to $2.51 in early Tuesday trading after the biopharmaceutical company announced that it has received orphan ...
April 25, 2023, 10:40 am
Genprex encouraged by latest reports on novel tumor suppressor
Genprex, Inc. (NASDAQ:GNPX) said independent researchers have reported that the tumor suppression gene used in its lead drug candidate REQORSA functio...
April 18, 2023, 11:06 am
Cns pharmaceuticals to present at the virtual investor gbm spotlight event
Live moderated video webcast with members of CNS Pharmacetucals management and Key Opinion Leader, Professor Michael Weller, MD, on Tuesday, April 4 t...
March 29, 2023, 9:05 am
Kintara therapeutics scheduled to present at two conferences the week of march 13, 2023
-35th Annual ROTH Conference, March 12-14, 2023 – -4th Annual glioblastoma Drug Development Summit, M...
March 10, 2023, 8:30 am
Novocure: ramifications of recent management change
As NovoCure Limited delivers hope in seemingly hopeless situations, Tumor Treating Field is already launched for mesothelioma and ...
February 7, 2023, 6:24 pm
Kazia to present final data from paxalisib phase ii study in glioblastoma at esmo
SYDNEY , Sept. 8, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, today announ...
September 8, 2022, 8:30 am
Midatech pharma boosted by european news on key product
Midatech Pharma PLC (AIM:MTPH) is in demand after a positive European approval for a key product. The biotechnology company said that the European Me...
June 21, 2022, 4:01 am
Vbi vaccines: recent vbi-1901 data supports my bull thesis
VBI Vaccines recently reported updated data from their VBI-1901 candidate in recurrent glioblastoma. Th...
June 17, 2022, 9:21 am
Midatech pharma's shares shoot higher on fda fast track designation for malignant brain tumor drug
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ: MTP) lead drug candidate MTX110 for t...
June 1, 2022, 11:32 am
Novocure: a stalwart with more upsides
Though there are many companies to choose from, I focus on leading innovators with either novel therapeutics or technologies. NovoCure is a premier de...
May 9, 2022, 6:38 am